Why are Rare Earths increasingly important both to China and the rest of the world? How is supply and demand met and which processes are holding up that supply chain from functioning optimally? What about the importance of secondary supply and recycling? All these questions and more are put to Roskill's Rare Earth's analyst David Merriman, who brings Proactive London up to date about this fascinating growing market and why investors should be keeping a sharp eye on it.
Meet Alliance Pharma PLC, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event, London , 24 January 2019. Register here »